University Of Notre Dame Du Lac Kodiak Sciences Inc. Transaction History

University Of Notre Dame Du Lac

  • $66.8 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$42.74 - $66.25 $782,184 - $1.21 Million
-18,301 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$38.18 - $73.95 $759,667 - $1.47 Million
-19,897 Reduced 52.09%
18,301 $873,000
Q4 2019

Feb 14, 2020
BUY
$13.9 - $76.65 $530,952 - $2.93 Million
38,198 New
38,198 $2.75 Million

Others Institutions Holding KOD

# of Institutions
97
Shares Held
39M
Call Options Held
6.5K
Put Options Held
5.8K
View Full List

About Kodiak Sciences Inc.

KOD Quotes by TradingView
  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $288M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track University Of Notre Dame Du Lac Portfolio

Follow University Of Notre Dame Du Lac and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

News

Stay updated on University Of Notre Dame Du Lac with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email